Quick Answer
Vaxcyte, Inc. reported Total Assets of $3.00 billion for fiscal year 2025.
Vaxcyte, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $3.00B | -14.5% |
| 2024 | $3.51B | +149.4% |
| 2023 | $1.41B | +39.9% |
| 2022 | $1.01B | +210.2% |
| 2021 | $324.34M | -17.4% |
| 2020 | $392.83M | +497.9% |
| 2019 | $65.70M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $3.17B | -10.9% | -4.0% |
| June 30, 2025 | $3.31B | +58.4% | -2.2% |
| March 31, 2025 | $3.38B | +61.5% | -3.8% |
| December 31, 2024 | $3.51B | +149.4% | -1.4% |
| September 30, 2024 | $3.56B | +137.9% | +70.5% |
| June 30, 2024 | $2.09B | +38.9% | -0.2% |
| March 31, 2024 | $2.09B | +107.4% | +48.5% |
| December 31, 2023 | $1.41B | +39.9% | -5.9% |
- Vaxcyte, Inc. showed a decrease of -14.5% in Total Assets compared to the prior fiscal year.
- Over the 2019–2025 period, Vaxcyte, Inc.’s total assets has grown by 4470.5% (from $65.70 million to $3.00 billion).
- The most recent figure is from Vaxcyte, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: